Ceryvyn Therapeutics-ADRCYVNY
13F holders, Q2 2024 (June 30)9holders +1
2new positions
1sold out
1famous investor
$1.93avg. 13F price*
At the end of Q2 2024, 9 institutions reported holding Ceryvyn Therapeutics-ADR (CYVNY) in their 13F filings, up 1 from Q1 2024. 2 opened new positions and 1 sold out. The largest holders were Regal Partners Ltd ($5.6M), Baker Bros. Advisors LP ($4.2M) and Victory Capital Management Inc. ($1.6M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Ceryvyn Therapeutics-ADR
- Filed as
- OPTHEA LTD (Q2 2024)
- CUSIP
- 68386J208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $67K |
| Exits | 1 | $86 |
All 13F filers, Q1 2024 → Q2 2024: 34,945 shares bought and 382,296 shares sold, net −347,351 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Regal Partners Ltd | 0.58% | No change | 2,907,403 | $5.6M |
| Baker Bros. Advisors LP | 0.05% | Reduce -0.2% | 2,173,622 | $4.2M |
| Victory Capital Management Inc. | 0.00% | Reduce -1.8% | 840,040 | $1.6M |
| Teacher Retirement System of Texas | 0.00% | Reduce -56.9% | 269,399 | $517K |
| Millennium Management | 0.00% | Reduce -3.3% | 71,169 | $137K |
| Bank of Montreal | 0.00% | Reduce -8.6% | 48,618 | $107K |
| Stratos Wealth Partners, LTD. | 0.00% | New | 28,550 | $55K |
| Royal Bank of Canada | 0.00% | New | 6,000 | $12K |
| Frazier Financial Advisors, LLC | 0.00% | Add +111.3% | 750 | $1K |
"% of holder's portfolio" is CYVNY's weight in each manager's 13F, not the share of Ceryvyn Therapeutics-ADR the manager owns.